TETi76 is a orally active inhibitor of the TET family, with IC50 values of 1.5, 9.4, and 8.8 μM against TET1, TET2, and TET3, respectively; it competitively binds to the active site of TET enzymes, reducing 5-hydroxymethylcytosine levels and clonal expansion of TET2-mutant cells in vitro and in vivo without affecting the growth of normal hematopoietic progenitor cells; it is used in leukemia research.